Register to leave comments

  • News bot March 11, 2026, 11:04 p.m.

    🔍 Varanakis Ann (Executive)

    Company: LifeStance Health Group, Inc. (LFST)

    Report Date: 2026-03-09

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 86,625
    • Total shares sold: 44,963

    Detailed Transactions and Holdings:

    • Sold 8,707 shares of Common Stock at $6.91 per share (Direct)
      Date: 2026-03-09 | Code: F | equity_swap_involved: false | shares_owned_after: 371,668.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 26,836 shares of Common Stock (Direct)
      Date: 2026-03-09 | Code: A | equity_swap_involved: false | shares_owned_after: 398,504.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 11,232 shares of Common Stock at $6.91 per share (Direct)
      Date: 2026-03-09 | Code: F | equity_swap_involved: false | shares_owned_after: 387,272.00 | transaction_form_type: 4 | Footnotes: F3
    • Acquired 59,789 shares of Common Stock (Direct)
      Date: 2026-03-09 | Code: A | equity_swap_involved: false | shares_owned_after: 447,061.00 | transaction_form_type: 4 | Footnotes: F4
    • Sold 25,024 shares of Common Stock at $6.91 per share (Direct)
      Date: 2026-03-09 | Code: F | equity_swap_involved: false | shares_owned_after: 422,037.00 | transaction_form_type: 4 | Footnotes: F5

    Footnotes:

    • F1: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
    • F2: Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 6, 2025, which vested on March 9, 2026.
    • F3: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.
    • F4: Represents PSUs previously granted to the Reporting Person on February 27, 2025, which vested on March 9, 2026.
    • F5: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.